AbbVie’s Aquipta has become the first once-daily oral therapy for both chronic and episodic migraine prevention to be recommended by NICE for NHS patients in England and W
An NHS trust has taken the pioneering step of applying to hold the marketing authorisation for a gene therapy for a rare disease that was abandoned by a biotech developer
More than half (52%) of people who participated in a major survey of the GB public were dissatisfied with the NHS, as staff shortages, strikes, and record waiting lists ta
Artificial intelligence software designed to tackle missed appointments and reduce waiting lists will see its use by the NHS ramp up after a successful pilot deployment.
Up to 25,000 people with ulcerative colitis (UC) in England could be in line for treatment with Pfizer’s once-daily oral therapy Velsipity, after NICE recommended its use
Healthcare systems need to address the impact of racial and ethnic biases in the design and use of medical devices, says a new independent review conducted in the UK.